The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF multi-stakeholder workshop (June 2017)

Innovation in Oncology Clinical Trial Design

Frankfurt, Germany, 12 & 13 June 2017

Final banner - Clinical Trials workshop

The CDDF multi-stakeholder workshop on Innovation in Oncology Clinical Trial Design aimed at discussing clinical trial study designs for oncology with current and recent challenges together with a multi-stakeholder audience of experts from academia, regulatory authorities, pharmaceutical industry and patient advocate groups.

The objective of the workshop was to:

  • better understand the position and concerns of the other stakeholders to ensure better study designs can be developed for more efficient drug development
  • to have a multi-stakeholder discussion representing oncologists/scientists, government officials (EMA, policymakers and HTA), pharmaceutical industry representatives and patient advocate groups interested in the topic.


  • Jaap Verweij (Erasmus MC)
  • Kinga Komar Malinowska (Bayer)
  • Stefan Schwoch (Lilly)
  • Irmela Radtke (F. Hoffmann La Roche Ltd)
  • Jan Gross (Merckgroup)


Final CDDF Workshop June 17 Programme


To access the slides, please click here


Verweij, J., Hendriks, H.R., Zwierzina, H. (2019) – on behalf of the CDDF. Innovation in oncology clinical trial design. Cancer Treatment Reviews, 74, 15-20.


twitter32x32Join the discussion on Twitter by using #CDDFworkshop

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70